OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
Zishuai Li, Zihan Zhang, Letian Fang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2083-2099
Open Access | Times Cited: 14
Zishuai Li, Zihan Zhang, Letian Fang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2083-2099
Open Access | Times Cited: 14
Showing 14 citing articles:
Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
Zeynep Akbulut, Başak Aru, Furkan Aydın, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Zeynep Akbulut, Başak Aru, Furkan Aydın, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Equol: a metabolite of gut microbiota with potential antitumor effects
Jing Lv, Shengkai Jin, Yuwei Zhang, et al.
Gut Pathogens (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Jing Lv, Shengkai Jin, Yuwei Zhang, et al.
Gut Pathogens (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Therapeutic potential of kakkatin derivatives against hepatocellular carcinoma
Sandeep K. Chahal, Vikram Patial
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 3
Closed Access
Sandeep K. Chahal, Vikram Patial
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 3
Closed Access
TGF-β signaling orchestrates cancer-associated fibroblasts in the tumor microenvironment of human hepatocellular carcinoma: unveiling insights and clinical significance
Junwei Ge, Hongwei� Jiang, Junjun Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Junwei Ge, Hongwei� Jiang, Junjun Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Total bile acid is a useful tool for evaluating the risk of portal hypertension in patients with hepatocellular carcinoma who have undergone hepatectomy
Xiaofeng Zhang, Xiaofeng Niu, Lixin Li, et al.
Current Medical Research and Opinion (2025), pp. 1-12
Closed Access
Xiaofeng Zhang, Xiaofeng Niu, Lixin Li, et al.
Current Medical Research and Opinion (2025), pp. 1-12
Closed Access
Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro
Yuanqin Du, Bin Yuan, Yi-Xian Ye, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 565-580
Open Access | Times Cited: 3
Yuanqin Du, Bin Yuan, Yi-Xian Ye, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 565-580
Open Access | Times Cited: 3
Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy
Yuting Gao, Yi Gong, Junlan Lu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Yuting Gao, Yi Gong, Junlan Lu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
[Hepatocellular Carcinoma-Derived Exosomes: Key Players in Intercellular Communication Within the Tumor Microenvironment].
Feng Tang, Xinrui Yang, Qiwei Wang, et al.
PubMed (2024) Vol. 55, Iss. 1, pp. 6-12
Closed Access
Feng Tang, Xinrui Yang, Qiwei Wang, et al.
PubMed (2024) Vol. 55, Iss. 1, pp. 6-12
Closed Access
Organic Nanomaterials Loaded with Cytotoxic Agents: A Therapeutic Alternative Against Cancer
Jorge L. Mejía-Méndez, Edgar R. López-Mena, Diego E. Navarro-López, et al.
Interdisciplinary cancer research (2024)
Closed Access
Jorge L. Mejía-Méndez, Edgar R. López-Mena, Diego E. Navarro-López, et al.
Interdisciplinary cancer research (2024)
Closed Access
ENG is a Biomarker of Prognosis and Angiogenesis in Liver Cancer, and Promotes the Differentiation of Tumor Cells into Vascular ECs
Shangheng Shi, Cunle Zhu, Yue Hu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 9
Open Access
Shangheng Shi, Cunle Zhu, Yue Hu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 9
Open Access
DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma
Guangyu Fan, Ruyun Gao, Tongji Xie, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access
Guangyu Fan, Ruyun Gao, Tongji Xie, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access
Integrated single-cell and bulk RNA sequencing reveals immune-related SPP1+ macrophages as a potential strategy for predicting the prognosis and treatment of liver fibrosis and hepatocellular carcinoma
Bin Li, Jialiang Hu, Hanmei Xu
Frontiers in Immunology (2024) Vol. 15
Open Access
Bin Li, Jialiang Hu, Hanmei Xu
Frontiers in Immunology (2024) Vol. 15
Open Access
Precise Carrier-Free Pt(IV)-Nanobombs for Apoptosis/Ferroptosis Synergistic Tumor Therapy: A New Effective Method to Obtain Good Chemotherapy and Low Toxicity
Xu Guo, Xin Liang, Jiale Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Xu Guo, Xin Liang, Jiale Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
